Endocrinologia
Estudo de coorte | Análise de comorbidades, desfechos clínicos e paratireoidectomia em adultos com hiperparatireoidismo primário.
14 Jun, 2022 | 13:31hEstudo relacionado: Mortality and Morbidity in Mild Primary Hyperparathyroidism: Results From a 10-Year Prospective Randomized Controlled Trial of Parathyroidectomy Versus Observation – Annals of Internal Medicine (link para o resumo – $ para o texto completo)
Comentário no Twitter
This national cohort study from Sweden found patients with primary hyperparathyroidism had an increased risk of fractures and cardiovascular events, and parathyroidectomy was associated with reduced risks for these outcomes. https://t.co/9dQAR9dqtk
— JAMA Network Open (@JAMANetworkOpen) June 3, 2022
Estudo de coorte | Incidência do diabetes tipo 2 de início recente após câncer.
14 Jun, 2022 | 13:28hIncidence of New-Onset Type 2 Diabetes After Cancer: A Danish Cohort Study – Diabetes Care
Comunicado de imprensa: Cancer Increases the Risk of Developing Diabetes – University of Copenhagen
Comentários no Twitter
We identify several cancers as risk factor for T2D with associated ↑21% risk of death as consequence. Fantastic cross-disciplinary collaboration @CASTLE_research @FessorC @FrederikPersson @NEXSKU @BiomedUCPH @ADA_DiabetesPro @Rigshospitalet @Stenodiabeteshttps://t.co/LYDsDXSGNB pic.twitter.com/PdOZffSjFf
— Lykke Sylow (@LykkeSylow) June 2, 2022
Patients with cancer are at higher risk for developing diabetes (esp patients with pancreatic cancer (HR 5.00), brain tumours (HR 1.54) and uterine cancer (HR 1.41) https://t.co/FzjepMrENA pic.twitter.com/PWDs5xsHOn
— K Pavithran (@drkpavithran) June 3, 2022
M-A | Eficácia comparativa de novos medicamentos antidiabéticos sobre os desfechos cardiovasculares e renais em pacientes com doença renal diabética.
14 Jun, 2022 | 13:08h#ADA2022 – Relatório de consenso ADA | Insuficiência cardíaca: uma complicação pouco notada do diabetes.
13 Jun, 2022 | 15:04h#ADA2022 – Estudo randomizado | Tirzepatida semanal para tratamento de obesidade.
13 Jun, 2022 | 15:03hTirzepatide Once Weekly for the Treatment of Obesity – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comunicado de imprensa: SURMOUNT-1 Study Finds Individuals with Obesity Lost up to 22.5% of their Body Weight when Taking Tirzepatide – American Diabetes Association
Comentário no Twitter
SURMOUNT-1: In an RCT, adults with obesity treated with weekly tirzepatide had major weight loss over 72 weeks. #ADA2022 https://t.co/X2RrvYxzsV pic.twitter.com/X27bWp1Qod
— NEJM (@NEJM) June 4, 2022
#ADA2022 – Estudo randomizado | Dulaglutida semanal para tratamento de jovens com diabetes tipo 2.
13 Jun, 2022 | 15:00hOnce-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comunicado de imprensa: Once Weekly Drug Helps Control Pediatric Type 2 Diabetes – American Diabetes Association
Comentário no Twitter
Trial compared once-weekly dulaglutide with placebo for glycemic control in youths with type 2 diabetes who may have been receiving metformin or basal insulin. Dulaglutide was superior at 26 weeks. #ADA2022 https://t.co/P6PubXvHOR pic.twitter.com/1JPIT5IyTe
— NEJM (@NEJM) June 4, 2022
#ADA2022 – Estudo de coorte retrospectiva | Associação entre cirurgia bariátrica e risco de câncer e mortalidade em adultos com obesidade.
13 Jun, 2022 | 14:58hAssociation of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity – JAMA (gratuito por tempo limitado)
Editorial: Bariatric Surgery and Cancer Risk – JAMA (gratuito por tempo limitado)
Comunicado de imprensa: Weight loss with bariatric surgery cuts the risk of developing cancer and death from cancer – Cleveland Clinic
Comentários no Twitter
In this study, among adults with #obesity, #bariatricsurgery compared with no surgery was associated with a significantly lower incidence of obesity-associated #cancer and cancer-related mortality. https://t.co/x2gz3RUdra
— JAMA (@JAMA_current) June 3, 2022
Retrospective cohort presented at the @AmDiabetesAssn: incidence rate of 3.0 events vs 4.6 events per 1,000 person-years, resp, & a 32% reduced risk for developing obesity-related cancer following weight loss via surgery. @ClevelandClinic
https://t.co/6jLDmhgJbR @JAMA_current
— Karl Nadolsky (@DrKarlNadolsky) June 4, 2022
Diretriz de consenso | Efeito de dietas com restrição de carboidratos e jejum intermitente sobre obesidade, diabetes melito tipo 2 e hipertensão.
13 Jun, 2022 | 14:49hEstudo de coorte | Desfechos gestacionais em mulheres jovens com diabetes tipo 2.
13 Jun, 2022 | 14:19h
Comentário no Twitter
Type 2 diabetes in youth is a severe disease.
Among 260 pregnancies reported in the TODAY study, 2/3rds with complications:
👉25% pregnancy loss
👉33% preterm birth
👉35% hypertension
👉27% large infantsNew prevention/treatment desperately neededhttps://t.co/SaMXAy4Xjz
— Dr. David Ludwig (@davidludwigmd) June 2, 2022
M-A | Tempo de tela e índice de massa corpórea entre crianças e adolescentes.
13 Jun, 2022 | 14:14hConteúdos relacionados:
M-A: Global prevalence of meeting screen time guidelines among children 5 years and younger.
Media and Young Minds – American Academy of Pediatrics